TY - JOUR
T1 - Coagulation patterns following haemoglobin-based oxygen carrier resuscitation in severe uncontrolled haemorrhagic shock in swine
AU - Arnaud, F.
AU - Handrigan, M.
AU - Hammett, M.
AU - Philbin, N.
AU - Rice, J.
AU - Dong, F.
AU - Pearce, L. B.
AU - McCarron, R.
AU - Freilich, D.
PY - 2006/8
Y1 - 2006/8
N2 - Massive blood loss due to penetrating trauma and internal organ damage can cause severe haemorrhagic shock (HS), leading to a severely compromised haemostatic balance. This study evaluated the effect of bovine polymerized haemoglobin (Hb) (Hb-based oxygen carrier, HBOC) resuscitation on haemostasis in a swine model of uncontrolled HS. Following liver injury/HS, swine received HBOC (n = 8), Hextend (HEX) (n = 8) or no resuscitation (NON) (n = 8). Fluids were infused to increase mean arterial pressure above 60 mmHg and to reduce heart rate to baseline. At 4 h, the animals were eligible for blood transfusions. Prothrombin time (PT), activated partial thromboplastin time, fibrinogen, thromboelastography (TEG) and platelet function analyser closure time (PFA-CT) were compared by using mixed statistical model. At 4 h, blood loss (% estimated blood volume) was comparable for HBOC (65.5 ± 18.5%) and HEX (80.8 ± 14.4%) and less for NON (58.7 ± 10.1%; P < 0.05). Resuscitation-induced dilutional coagulopathy was observed with HBOC and HEX, as indicated by reduced haematocrit, platelets and fibrinogen (P < 0.05). At 4 h, PT was higher in HEX than in HBOC groups (P < 0.01). In the early hospital phase, a trend to increased TEG reaction time and PFA-CT indicates that dilutional effects persist in HBOC and HEX groups. PFA-CT returned to baseline later with HBOC than with HEX (48 vs. 24 h) following blood transfusion. At 4 h, all surviving HEX animals (n = 3) required transfusion, in contrast to no HBOC (n = 7) or NON (n = 1) animals. In this severe uncontrolled HS model, successful resuscitation with HBOC produced haemodilutional coagulopathy less than or similar to that produced by resuscitation with HEX.
AB - Massive blood loss due to penetrating trauma and internal organ damage can cause severe haemorrhagic shock (HS), leading to a severely compromised haemostatic balance. This study evaluated the effect of bovine polymerized haemoglobin (Hb) (Hb-based oxygen carrier, HBOC) resuscitation on haemostasis in a swine model of uncontrolled HS. Following liver injury/HS, swine received HBOC (n = 8), Hextend (HEX) (n = 8) or no resuscitation (NON) (n = 8). Fluids were infused to increase mean arterial pressure above 60 mmHg and to reduce heart rate to baseline. At 4 h, the animals were eligible for blood transfusions. Prothrombin time (PT), activated partial thromboplastin time, fibrinogen, thromboelastography (TEG) and platelet function analyser closure time (PFA-CT) were compared by using mixed statistical model. At 4 h, blood loss (% estimated blood volume) was comparable for HBOC (65.5 ± 18.5%) and HEX (80.8 ± 14.4%) and less for NON (58.7 ± 10.1%; P < 0.05). Resuscitation-induced dilutional coagulopathy was observed with HBOC and HEX, as indicated by reduced haematocrit, platelets and fibrinogen (P < 0.05). At 4 h, PT was higher in HEX than in HBOC groups (P < 0.01). In the early hospital phase, a trend to increased TEG reaction time and PFA-CT indicates that dilutional effects persist in HBOC and HEX groups. PFA-CT returned to baseline later with HBOC than with HEX (48 vs. 24 h) following blood transfusion. At 4 h, all surviving HEX animals (n = 3) required transfusion, in contrast to no HBOC (n = 7) or NON (n = 1) animals. In this severe uncontrolled HS model, successful resuscitation with HBOC produced haemodilutional coagulopathy less than or similar to that produced by resuscitation with HEX.
KW - Haemostasis
KW - Oxygen carriers
KW - Resuscitation
KW - Swine model
KW - Transfusion
KW - Trauma
UR - http://www.scopus.com/inward/record.url?scp=33746458494&partnerID=8YFLogxK
U2 - 10.1111/j.1365-3148.2006.00678.x
DO - 10.1111/j.1365-3148.2006.00678.x
M3 - Article
C2 - 16879158
AN - SCOPUS:33746458494
SN - 0958-7578
VL - 16
SP - 290
EP - 302
JO - Transfusion Medicine
JF - Transfusion Medicine
IS - 4
ER -